Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL, Rudneva VA, Richards AL, Zhang Y, Woo HJ, Cohen M, Tisnado J, Majd N, Wardlaw SL, Page-Wilson G, Sengupta S, Chow F, Goichot B, Ozer BH, Dietrich J, Nachtigall L, Desai A, Alano T, Ogilive S, Solit DB, Bale TA, Rosenblum M, Donoghue MTA, Geer EB, Tabar V.
Lin AL, et al. Among authors: page wilson g.
Acta Neuropathol. 2024 May 17;147(1):85. doi: 10.1007/s00401-024-02736-8.
Acta Neuropathol. 2024.
PMID: 38758238
Free PMC article.